Clene Inc.

NasdaqCM:CLNN Stock Report

Market Cap: US$39.9m

Clene Management

Management criteria checks 3/4

Clene's CEO is Rob Etherington, appointed in Apr 2013, has a tenure of 11.67 years. total yearly compensation is $1.71M, comprised of 38.3% salary and 61.7% bonuses, including company stock and options. directly owns 0.53% of the company’s shares, worth $210.17K. The average tenure of the management team and the board of directors is 2.8 years and 4 years respectively.

Key information

Rob Etherington

Chief executive officer

US$1.7m

Total compensation

CEO salary percentage38.3%
CEO tenure11.7yrs
CEO ownership0.5%
Management average tenure2.8yrs
Board average tenure4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Rob Etherington's remuneration changed compared to Clene's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$36m

Jun 30 2024n/an/a

-US$30m

Mar 31 2024n/an/a

-US$49m

Dec 31 2023US$2mUS$654k

-US$50m

Sep 30 2023n/an/a

-US$40m

Jun 30 2023n/an/a

-US$49m

Mar 31 2023n/an/a

-US$28m

Dec 31 2022US$2mUS$561k

-US$30m

Sep 30 2022n/an/a

-US$24m

Jun 30 2022n/an/a

US$15m

Mar 31 2022n/an/a

US$17m

Dec 31 2021US$5mUS$510k

-US$10m

Sep 30 2021n/an/a

-US$13m

Jun 30 2021n/an/a

-US$53m

Mar 31 2021n/an/a

-US$55m

Dec 31 2020US$498kUS$335k

-US$19m

Sep 30 2020n/an/a

-US$24m

Jun 30 2020n/an/a

-US$19m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$510kUS$335k

-US$16m

Dec 31 2018US$465kUS$335k

-US$12m

Compensation vs Market: Rob's total compensation ($USD1.71M) is above average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Rob's compensation has been consistent with company performance over the past year.

CEO

Rob Etherington (57 yo)

11.7yrs

Tenure

US$1,706,605

Compensation

Mr. Robert Etherington, also known as Rob, MBA, serves as Chief Executive officer, President and Director at Clene Nanomedicine, Inc. He serves as President, Chief Executive Officer and Director at Clene...

Leadership Team

NamePositionTenureCompensationOwnership
Robert Etherington
CEO, President & Director11.7yrsUS$1.71m0.53%
$ 210.2k
Morgan Brown
Chief Financial Officer2.8yrsUS$993.70k0%
$ 0
Mark Mortenson
Chief Science Officerno dataUS$1.38m0.36%
$ 144.7k
Jerry Miraglia
General Counsel & Corporate Secretaryno datano datano data
Michael Hotchkin
Chief Development Officerno datano datano data
Mary Mcneil
Head of Human Resourcesno datano datano data
Benjamin Greenberg
Head of Medical1.8yrsno datano data

2.8yrs

Average Tenure

57yo

Average Age

Experienced Management: CLNN's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Robert Etherington
CEO, President & Director11.7yrsUS$1.71m0.53%
$ 210.2k
David Matlin
Independent Chairman of the Board4yrsUS$99.65k5.66%
$ 2.3m
Reed Wilcox
Independent Director11.8yrsno data0.36%
$ 143.8k
Jonathon Gay
Independent Director4yrsUS$67.50k0.11%
$ 43.6k
Alison Mosca
Independent Director5.3yrsUS$82.64k4.96%
$ 2.0m
Arjun Desai
Independent Director1.3yrsUS$31.09k0.010%
$ 4.1k
Shalom Jacobovitz
Independent Director11.8yrsUS$81.14k0.047%
$ 18.8k
Matthew Kiernan
Independent Director1.3yrsUS$29.59k0.0053%
$ 2.1k
Vallerie McLaughlin
Independent Director3.3yrsUS$65.63k0%
$ 0

4.0yrs

Average Tenure

58.5yo

Average Age

Experienced Board: CLNN's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 07:34
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Clene Inc. is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bruce JacksonBenchmark Company
Sumant Satchidanand KulkarniCanaccord Genuity
Charles DuncanCantor Fitzgerald & Co.